Demodex (Mange Mite)

  • Current Advice on Parasite Control:

    Ectoparasites - Demodex (Mange Mite)

    Last reviewed and edited Mar 2013

  • Species

    Demodex_multi_2.jpgCanine
    Demodex canis
    Demodex injai
    Demodex
    sp. "cornei"

    Feline
    Demodex cati
    Demodex gatoi
    Demodex
    sp.

  • Overview of Life Cycle

    • Most Demodex spp. are considered normal mammalian fauna.
    • Neonates are thought to typically acquire mites from the dam via direct skin-to-skin contact, but most individual animals do not develop clinical disease.
    • All stages of the life cycle (eggs, larvae, nymphs, adults) reside within the lumen of hair follicles and within sebaceous gland ducts; some species are more commonly found in the stratum corneum.
    • Development from egg to adult takes approximately 20 to 35 days and is completed entirely on the host.
  • Stages

    • Six-legged larvae hatch from fusiform-shaped eggs and undergo several molts to become eight-legged nymphs and ultimately adults.
    • Adults are eight-legged, slender, and elongated mites; their appearance is often described as cigar-shaped.
    • In the canine Demodex species, the length of adult mites ranges from 180 to 210 µm for D. canis, 330 to 370 µm for D. injai, and 90 to 140 µm for Demodex sp. “cornei”.
    • In the feline Demodex species, the length of adult mites ranges from 181 to 219 µm for D. cati, 81 to 115 µm for Demodex gatoi, and 170-174 µm for Demodex sp.

    d.canis.jpg

    d.injai.jpg

     

     

     

     

     

     

    image.jpg

     d.cati.jpg

     

     

     

     

     

    d.gatoi.jpg

     

     

    d.gatoi.egg.jpg

  • Disease

    • Although most Demodex spp. are considered normal mammalian fauna, overgrowth of mites may be associated with development of patchy hair loss or mild to severe dermatitis in dogs and (less commonly) in cats.
    • In cases of demodicosis caused by Demodex sp. “cornei” or D. gatoi in cats, disease is thought to be caused by the infestation itself rather than an overgrowth of mites and can be associated with pruritus in the absence of pyoderma.

    Dogs

    • Canine demodicosis may be localized or generalized and both forms may present in either juvenile or adult dogs.
    • Pruritus does not occur in uncomplicated infestations; however, pruritus can be seen with secondary bacterial pyoderma.
    • In dogs, localized demodicosis—characterized by a mild, nonpruritic, patchy alopecia on the head or limbs—usually develops in puppies less than 6 months of age. Most cases of juvenile-onset localized demodicosis resolve spontaneously without treatment. For that reason, the remainder of this recommendation in regards to dogs will focus on generalized demodicosis as localized demodicosis is not considered severe nor does it require treatment.
    • Generalized demodicosis in dogs is a moderate to severe disease that in most cases is attributable to an overgrowth of mites believed to occur because of an underlying systemic disease or immune defect. With Demodex sp. ”cornei”, however, the infestation itself is thought to cause disease.
    • Physical examination findings include alopecia (which may involve several large to coalescing areas of affected skin), erythema, and often secondary superficial or deep pyoderma. Lymph nodes may be enlarged, and when pyoderma is present, pruritus may develop.

    Cats

    • Cats with localized demodicosis develop alopecia and crusts as well as some scaling around the face, neck, and eyelids, with varying degree of hyperpigmentation.
    • Generalized demodicosis due to overgrowth of D. cati is usually associated with underlying systemic disease.
    • Cats infested with D. gatoi are pruritic and may excessively lick or groom affected areas. In cats with D. gatoi, dermatitis is not associated with underlying disease.
  • Prevalence

    • Canine demodicosis (demodectic mange) due to D. canis is a common skin disease in the dog; disease due to D. injai or Demodex sp. “cornei” in dogs appears to be rare.
    • Feline demodicosis due to D. cati is rare, and feline demodicosis due to D. gatoi is even less common, although cases are reported from the southeastern United States.
  • Host Associations and Transmission Between hosts

    • Demodex spp. are host-adapted mites of mammals. Mites have not been shown to cross-infest between dogs and cats, nor are they transmitted to people. Neonates are thought to acquire mites from their dam via direct skin-to-skin contact during nursing.
    • Transmission of mites may also occur during direct contact between older animals, but demodectic mange is not contagious as most animals that develop generalized demodicosis are thought to have an underlying immune defect (see Disease).
    • Demodex gatoi is a superficial species reported from cats and is thought to be contagious among cats.
  • Site of Infestation

    • Demodex canis and D. cati infest hair follicles and sebaceous glands.
    • Mites may occasionally be reported from other tissues (e.g., lymph node, intestinal wall, kidney, thyroid gland) following dissemination via blood or lymphatic drainage.
    • Early studies of nursing neonatal puppies have found D. canis mites initially within the skin of the face, and then over time mites are transferred throughout the skin of the entire body. Mites are not found in the skin of stillborn puppies or puppies born by Caesarian that are not allowed to nurse.
    • Localized demodicosis in dogs most commonly develops on the head or limbs; the lesions of generalized canine demodicosis may develop anywhere on the body.
    • Demodex gatoi infestation in cats is most frequently reported from the groin, ventral chest, and sometimes limbs.
  • Pathogenesis

    • The immunopathogenesis of demodicosis is not fully understood, and in most cases an underlying cause is not identified. Although a responsible condition is not always identified, many cases of generalized demodicosis appear to be the direct result of underlying diseases that compromise the immune system. Excessive cortisone, poor nutrition, chemotherapy, and underlying cancer or diabetes have all been associated with the development of generalized demodicosis in individual animals. Accordingly, dogs and cats with generalized demodicosis should be carefully evaluated for potential underlying disease states.
    • No specific deficits in innate or humoral immunity have been identified in dogs with generalized demodicosis. However, some studies suggest that cellular immunity may be compromised in some individuals that go on to develop generalized demodicosis.
  • Diagnosis

    • Demodicosis due to D. canis, D. injai, and D. cati is diagnosed by microscopic examination of deep skin scrapes from affected areas of alopecia.
    • Alternatively, in uncooperative dogs or sensitive areas in which skin scrape is difficult (e.g., feet, interdigital region), hairs may be plucked from an affected area and placed in mineral oil on a slide for microscopic examination.
    • Because Demodex sp. “cornei” and D. gatoi in cats reside within the stratum corneum, superficial skin scraping or tape impression offers a better method for detecting these mites. Because the pruritus associated with D. gatoi infestations leads to removal of the mites by grooming, they often are difficult to find.
    • In rare cases of “occult demodicosis,” i.e., no mites are observed with either the skin-scraping or hair-pluck techniques, a skin biopsy may demonstrate Demodex mites. The mites (or mite fragments) can be seen within the lumen of the hair follicles or (rarely) within the sebaceous glands/ducts, depending on the type of mite. This technique may be necessary in Demodex cases involving the feet and in the Chinese Shar Pei.
  • Treatment

    Dogs- Localized Demodicosis

    • Most cases of localized demodicosis resolve spontaneously without treatment.
    • If treatment is desired, a rotenone-based insecticide ointment (Goodwinol) has been approved. Although the ointment is miticidal, localized irritation may occur.

    Dogs- Generalized Demodicosis

    • Generalized demodicosis may require extended, aggressive therapy to resolve disease.
    • Comprehensive treatment should include use of an effective miticide, evaluation for any underlying disorders and appropriate treatment when found, antibiotic therapy when pyoderma is present, and spaying of female dogs to prevent recurrence during subsequent heat cycles.
    • Several months of treatment may be required to eliminate the mites. Selected treatment should be continued for 1 to 2 months after mites are no longer detected on skin scrape.
    • Amitraz dip (Mitaban®) at 250 ppm every 2 weeks is the only approved miticidal treatment for generalized demodicosis in the United States.
      • Hair should be clipped throughout treatment; dogs should be allowed to air-dry or should be dried with a blow dryer after each application.
      • Use of a benzoyl peroxide shampoo prior to the application of amitraz dip is recommended; dogs should not be shampooed between applications.
      • Some practitioners recommend weekly dips or a more concentrated formulation (e.g., 500 ppm) in refractory cases or to clear dogs more rapidly.
      • Side effects may occur and are detailed on the product label. The risk of side effects increases with increased concentration of dip solution.
      • Key safety recommendations when using amitraz dip include application of the product in a well-ventilated area and use of protective gloves and a mask during application.
      • Asthmatics and diabetics should exercise particular caution when handling dogs that have been treated with amitraz.
    • Other miticidal treatments not labeled in the United States include high-dose oral ivermectin, oral milbemycin oxime, topical moxidectin, and injectable doramectin.
      • Some dogs, particularly herding breeds such as Collies, Shetland Sheepdogs, Border Collies, Australian Shepherds, and Old English Sheepdogs, may have mutations in their MDR1 genes and thus have increased risk of toxicity to this class of drugs. Treatment should be discontinued if any neurologic signs develop. Practitioners can determine whether a dog has the MDR1 mutation by sending a cheek scraping to the Washington State University at Pullman College of Veterinary Medicine Veterinary Clinical Pharmacology Lab for analysis (http://www.vetmed.wsu.edu/depts-VCPL/test.aspx)..
      • Ivermectin may be given orally at escalating doses using 100 µg/kg increments. Begin with 100 µg/kg for 3 days followed by 200 µg/kg for 3 days followed by 300 µg/kg. Some practitioners recommend remaining at the 300-µg/kg dose whereas others recommend continuing to increase the dose every 3 days to 600 µg/kg.
      • Milbemycin oxime  has also been used daily at doses ranging from 0.5 to 2 mg/kg. Doses are escalated gradually, building to a final dose of 1.5 to 2.0 mg/kg. 
      • Moxidectin/imidacloprid topical carries a label claim in Europe for treatment of D. canis infestation at the standard labeled dose. Treatment is more effective when administered every two weeks.
      • Doramectin may be injected subcutaneously once a week at the dose of 600 µg/kg in dogs negative for the MDR1 gene mutation.

    Cats

    • No products are labeled for demodicosis in cats.
    • Treatment should be continued for 1-2 months after mites are no longer detected on skin scrape.
    • Lime sulfur dips have been reported effective. Dips should be performed weekly for 6 weeks with 3.1% solution (4 ounces per gallon of water). Skin irritation may occur.
    • Ivermectin has been used once weekly at 0.3 mg/kg orally for four consecutive weeks. Side effects may occur.
    • Amitraz has been used in cats at a 0.0125 to 0.025% solution every 5 to 7 days for 4 to 6 weeks. Side effects may occur.
  • Control and Prevention

    • For intact female dogs that develop generalized demodicosis, spaying is recommended because they may experience relapse of disease in subsequent heat cycles.
    • The development of demodicosis was long believed to have a genetic predisposition, and as a result, some veterinarians discourage breeding affected animals. The propensity to develop localized demodicosis is hereditary, however, the hereditary nature of generalized demodicosis has not been clearly demonstrated.
  • Public Health Considerations

    • Demodex mites are host-adapted; there is no zoonotic potential in either canine or feline demodicosis.
  • Selected References

    • Mueller RS. An update on the therapy of canine demodicosis. Compend Contin Educ Vet 34:E1-4, 2012.
    • de Rojas M, Riazzo C, Callejón R, Guevara D, Cutillas C. Molecular study on three morphotypes of Demodex mites (Acarina: Demodicidae) from dogs. Parasitol Res 111: 2165-2172, 2012.
    • Beale K. Feline demodicosis: a consideration in the itchy or overgrooming cat. J Feline Med Surg 14: 209-213, 2012.
    • Kano R, Hyuga A, Matsumoto J, Nogami S, Nemoto S, Haseqawa A, Kamata H. Feline demodicosis caused by an unnamed species. Res Vet Sci 92:257-258, 2012.